23 October 2020 - One of the most significant phenomena in the recent years concerning the pharmaceutical industry and, at the same time, payers in health care systems, is the sharp acceleration in the growth of new drug prices.
Sustainability is being discussed across the board and every healthcare system deals with it in different ways, in particular pricing and reimbursement mechanisms.